Sònia Abad

1.0k total citations
18 papers, 807 citations indexed

About

Sònia Abad is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Physiology. According to data from OpenAlex, Sònia Abad has authored 18 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Pharmacology and 9 papers in Physiology. Recurrent topics in Sònia Abad's work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Sònia Abad is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Sònia Abad collaborates with scholars based in Spain, Chile and Mexico. Sònia Abad's co-authors include Antoni Camins, Jaume Folch, Dmitry S. Petrov, Miren Ettcheto, Jordi Olloquequi, Carlos Beas‐Zárate, Ignacio Pedrós, Carme Auladell, Miguel Marín and David Pubill and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Psychiatry.

In The Last Decade

Sònia Abad

18 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sònia Abad Spain 15 327 229 219 208 117 18 807
Mehrak Javadi‐Paydar Iran 19 210 0.6× 362 1.6× 174 0.8× 259 1.2× 116 1.0× 43 924
Carina Rodrigues Boeck Brazil 21 150 0.5× 396 1.7× 75 0.3× 274 1.3× 105 0.9× 57 1.1k
Corina Bejar Israel 17 308 0.9× 241 1.1× 400 1.8× 216 1.0× 159 1.4× 21 1.1k
Gaurav Bedse Italy 22 327 1.0× 487 2.1× 560 2.6× 248 1.2× 105 0.9× 26 1.3k
Carmela Belardo Italy 20 454 1.4× 295 1.3× 400 1.8× 273 1.3× 107 0.9× 40 1.1k
Radhakrishnan Mahesh India 22 130 0.4× 359 1.6× 198 0.9× 395 1.9× 70 0.6× 72 1.3k
Tuane Bazanella Sampaio Brazil 15 153 0.5× 236 1.0× 106 0.5× 175 0.8× 100 0.9× 44 830
Ildikó Rácz Germany 12 179 0.5× 389 1.7× 284 1.3× 306 1.5× 106 0.9× 21 968
Ruibin Su China 22 330 1.0× 945 4.1× 183 0.8× 775 3.7× 55 0.5× 103 1.6k
Gail Rauw Canada 13 182 0.6× 201 0.9× 102 0.5× 148 0.7× 80 0.7× 30 629

Countries citing papers authored by Sònia Abad

Since Specialization
Citations

This map shows the geographic impact of Sònia Abad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sònia Abad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sònia Abad more than expected).

Fields of papers citing papers by Sònia Abad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sònia Abad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sònia Abad. The network helps show where Sònia Abad may publish in the future.

Co-authorship network of co-authors of Sònia Abad

This figure shows the co-authorship network connecting the top 25 collaborators of Sònia Abad. A scholar is included among the top collaborators of Sònia Abad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sònia Abad. Sònia Abad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abad, Sònia, Raúl López‐Arnau, Jaume Folch, et al.. (2019). Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice. Journal of Psychopharmacology. 33(9). 1170–1182. 8 indexed citations
2.
Astori, Simone, et al.. (2019). Latency to Reward Predicts Social Dominance in Rats: A Causal Role for the Dopaminergic Mesolimbic System. Frontiers in Behavioral Neuroscience. 13. 69–69. 14 indexed citations
3.
Kooij, Michael A. van der, Fiona Hollis, Ioannis Zalachoras, et al.. (2017). Diazepam actions in the VTA enhance social dominance and mitochondrial function in the nucleus accumbens by activation of dopamine D1 receptors. Molecular Psychiatry. 23(3). 569–578. 95 indexed citations
4.
Ettcheto, Miren, Sònia Abad, Dmitry S. Petrov, et al.. (2017). Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease. Molecular Neurobiology. 55(6). 4885–4895. 23 indexed citations
5.
Folch, Jaume, Miren Ettcheto, Dmitry S. Petrov, et al.. (2017). Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein. SHILAP Revista de lepidopterología. 33(1). 47–58. 77 indexed citations
6.
Abad, Sònia, et al.. (2016). Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(9). 1815–1826. 8 indexed citations
7.
Folch, Jaume, Dmitry S. Petrov, Miren Ettcheto, et al.. (2016). Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment. Neural Plasticity. 2016. 1–15. 215 indexed citations
8.
Abad, Sònia, Jorge Camarasa, David Pubill, Antoni Camins, & Elena Escubedo. (2015). Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits. Molecular Neurobiology. 53(10). 7271–7283. 20 indexed citations
9.
Petrov, Dmitry S., Ignacio Pedrós, Miren Ettcheto, et al.. (2015). Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer’s Disease. Molecular Neurobiology. 53(9). 6183–6193. 24 indexed citations
10.
Folch, Jaume, Dmitry S. Petrov, Miren Ettcheto, et al.. (2015). Masitinib for the treatment of mild to moderate Alzheimer’s disease. Expert Review of Neurotherapeutics. 15(6). 587–596. 58 indexed citations
11.
Folch, Jaume, Miren Ettcheto, Dmitry S. Petrov, et al.. (2015). Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide. Neurología. 33(1). 47–58. 81 indexed citations
12.
Folch, Jaume, Ignacio Pedrós, Dmitry S. Petrov, et al.. (2015). The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. Life Sciences. 140. 19–28. 34 indexed citations
13.
Abad, Sònia, Fèlix Junyent, Carme Auladell, et al.. (2014). 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 54. 231–242. 9 indexed citations
14.
López‐Arnau, Raúl, José Martínez-Clemente, Sònia Abad, et al.. (2014). Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse. Psychopharmacology. 231(16). 3119–3129. 24 indexed citations
15.
Pedrós, Ignacio, Dmitry S. Petrov, Gonzalo Artiach, et al.. (2014). Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease. The journal of nutrition health & aging. 19(4). 403–412. 18 indexed citations
16.
Martínez-Clemente, José, Raúl López‐Arnau, Sònia Abad, et al.. (2014). Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice. PLoS ONE. 9(6). e99002–e99002. 55 indexed citations
17.
Abad, Sònia, Alberto Fole, Nuria Del Olmo, et al.. (2013). MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density. Psychopharmacology. 231(5). 863–874. 26 indexed citations
18.
Escubedo, Elena, Sònia Abad, Imma Torres, Jorge Camarasa, & David Pubill. (2010). Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity. Neurochemistry International. 58(1). 92–101. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehrak Javadi‐Paydar Breakdown of academic impact, for papers by Carina Rodrigues Boeck Breakdown of academic impact, for papers by Corina Bejar Breakdown of academic impact, for papers by Gaurav Bedse Breakdown of academic impact, for papers by Carmela Belardo Breakdown of academic impact, for papers by Radhakrishnan Mahesh Breakdown of academic impact, for papers by Tuane Bazanella Sampaio Breakdown of academic impact, for papers by Ildikó Rácz Breakdown of academic impact, for papers by Ruibin Su Breakdown of academic impact, for papers by Gail Rauw
Rankless by CCL
2026